Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8998 USD | -0.39% | -2.49% | -34.80% |
04-26 | Bluebird bio Gets Nasdaq Notice for Late Filing of Annual Report | MT |
03-27 | Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating | MT |
MarketScreener Editorial Features
Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease | December 11, 2023 at 05:47 am | |
Global markets live: Valneva, Volkswagen, Uber, Tesla, Apple... | September 19, 2022 at 11:43 am | |
Let the countdown begin | September 19, 2022 at 10:12 am | |
MarketScreener's World Press Review : August 18, 2022 | August 18, 2022 at 08:17 am | |
Global markets live: General Motors, JP Morgan, Pfizer, Novavax, Ford... | December 13, 2021 at 11:16 am | |
Today on Wall Street: Busy week ahead | December 13, 2021 at 09:43 am |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- MarketScreener Editorial Features